Fortress Biotech (FBIO) Other Non-Current Assets (2012 - 2026)

Fortress Biotech's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets fell 21.39% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (down 21.39% YoY), while the FY2025 annual figure was $1.2 million, down 21.39% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $1.2 million, down from $18.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $18.1 million in Q3 2025, with the low at $943000.0 in Q1 2023.
• The 5-year median for Other Non-Current Assets is $2.2 million (2021), against an average of $2.9 million.
• The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets sank 93.24% in 2021, then jumped 440.57% in 2025.
• Fortress Biotech's Other Non-Current Assets stood at $2.2 million in 2021, then sank by 56.17% to $973000.0 in 2022, then surged by 150.57% to $2.4 million in 2023, then plunged by 36.34% to $1.6 million in 2024, then declined by 21.39% to $1.2 million in 2025.
• Business Quant data shows FBIO's Other Non-Current Assets at $1.2 million in Q4 2025, $18.1 million in Q3 2025, and $3.0 million in Q2 2025.